Clinical and preclinical pulmonary disease in newly diagnosed rheumatoid arthritis: a two-year follow-up study.
Charlotte HyldgaardStefan M W HardersJ BlegvadMette HerlyDženan MašićBjørk Khaliqi SofíudóttirG UrbonavicieneF D AndersenChristin IsaksenBrian Bridal LøgstrupTorkell J EllingsenPublished in: Scandinavian journal of rheumatology (2023)
Emphysema and bronchiectasis were common, but most patients had mild disease with preserved lung function. Preclinical or clinical ILD was seen in a minority in this early phase of RA. These findings suggest symptom-based screening and primary intervention focusing on smoking cessation rather than screening for ILD at the time of RA diagnosis.
Keyphrases
- lung function
- newly diagnosed
- rheumatoid arthritis
- interstitial lung disease
- smoking cessation
- cystic fibrosis
- disease activity
- end stage renal disease
- chronic obstructive pulmonary disease
- systemic sclerosis
- air pollution
- chronic kidney disease
- randomized controlled trial
- ejection fraction
- replacement therapy
- cell therapy
- ankylosing spondylitis
- idiopathic pulmonary fibrosis
- pulmonary hypertension
- systemic lupus erythematosus
- stem cells
- peritoneal dialysis